miR-622 is a novel potential biomarker of breast carcinoma and impairs motility of breast cancer cells through targeting NUAK1 kinase.
Orlandella FM, Mariniello RM, Mirabelli P, De Stefano AE, Iervolino PLC, Lasorsa VA, Capasso M, Giannatiempo R, Rongo M, Incoronato M, Messina F, Salvatore M, Soricelli A, Salvatore G.
Orlandella FM, et al. Among authors: salvatore g, salvatore m.
Br J Cancer. 2020 Aug;123(3):426-437. doi: 10.1038/s41416-020-0884-9. Epub 2020 May 18.
Br J Cancer. 2020.
PMID: 32418991
Free PMC article.